Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AFAC
Arena Fortify Acquisition
$10.27
$10.25
$9.55
$10.81
$221.45MN/A60,151 shs2,630 shs
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$1.76
-1.1%
$6.91
$1.70
$30.50
$119.29M-0.932.84 million shs5.22 million shs
GEEX
Games & Esports Experience Acquisition
$10.53
$10.51
$9.95
$11.12
$263.25M0.01135,600 shs1,168 shs
Hour Loop, Inc. stock logo
HOUR
Hour Loop
$1.07
+0.9%
$1.24
$0.90
$4.89
$37.56M1.2737,776 shs19,574 shs
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
$9.61
-22.7%
$10.51
$7.50
$15.40
N/AN/A2,956 shs10,700 shs
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
$4.51
$4.52
$4.08
$12.03
$71.35M-0.0830,930 shs12,500 shs
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
$14.94
-0.4%
$15.40
$10.44
$19.12
$137M-0.3126,732 shs37,493 shs
Smart for Life, Inc. stock logo
SMFL
Smart for Life
$4.05
+15.7%
$5.18
$2.27
$478.17
$446K0.86552,915 shs579,872 shs
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
$10.55
$10.62
$10.05
$11.37
$162.79M0.03106,692 shs16,749 shs
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
$2.71
+5.0%
$3.12
$2.50
$11.11
$101.84M1.7797,720 shs46,559 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AFAC
Arena Fortify Acquisition
0.00%0.00%0.00%0.00%0.00%
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
-5.32%-10.10%-35.04%-88.43%-93.75%
GEEX
Games & Esports Experience Acquisition
0.00%0.00%0.00%0.00%0.00%
Hour Loop, Inc. stock logo
HOUR
Hour Loop
-5.36%-6.19%-27.40%-17.75%-31.61%
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
0.00%0.00%0.00%0.00%-9.60%
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
0.00%0.00%0.00%-40.50%-57.65%
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
-1.19%+0.87%-12.84%-0.30%+35.75%
Smart for Life, Inc. stock logo
SMFL
Smart for Life
-19.72%+8.11%-31.03%-65.75%-98.65%
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
0.00%0.00%0.00%0.00%-0.94%
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
-6.86%-6.18%-7.53%-13.42%-68.19%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AFAC
Arena Fortify Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3.3433 of 5 stars
4.12.00.00.00.63.31.9
GEEX
Games & Esports Experience Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Hour Loop, Inc. stock logo
HOUR
Hour Loop
N/AN/AN/AN/AN/AN/AN/AN/A
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
1.5781 of 5 stars
0.03.01.70.01.51.71.9
Smart for Life, Inc. stock logo
SMFL
Smart for Life
N/AN/AN/AN/AN/AN/AN/AN/A
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
1.9523 of 5 stars
3.32.00.00.00.03.31.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AFAC
Arena Fortify Acquisition
N/AN/AN/AN/A
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
2.25
Hold$32.671,756.06% Upside
GEEX
Games & Esports Experience Acquisition
N/AN/AN/AN/A
Hour Loop, Inc. stock logo
HOUR
Hour Loop
N/AN/AN/AN/A
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
N/AN/AN/AN/A
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
N/AN/AN/AN/A
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
N/AN/AN/AN/A
Smart for Life, Inc. stock logo
SMFL
Smart for Life
N/AN/AN/AN/A
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
N/AN/AN/AN/A
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
2.50
Moderate Buy$17.40542.07% Upside

Current Analyst Ratings

Latest MDV, AMLX, VIGL, LGST, TOAC, IOACU, AFAC, GEEX, SMFL, and HOUR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$23.00
4/8/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
3/27/2024
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00
3/18/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/11/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
3/11/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
3/11/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral
3/8/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
3/8/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ In-Line
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AFAC
Arena Fortify Acquisition
N/AN/AN/AN/AN/AN/A
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$380.79M0.31$0.56 per share3.14$6.42 per share0.27
GEEX
Games & Esports Experience Acquisition
N/AN/AN/AN/AN/AN/A
Hour Loop, Inc. stock logo
HOUR
Hour Loop
$132.12M0.28N/AN/A$0.13 per share8.23
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
N/AN/AN/AN/AN/AN/A
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
N/AN/A$0.33 per share13.74($1.10) per shareN/A
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
$46.94M2.92$0.27 per share56.18$29.66 per share0.50
Smart for Life, Inc. stock logo
SMFL
Smart for Life
$17.77M0.03N/AN/A($206.07) per share-0.02
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
N/AN/AN/AN/AN/AN/A
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
N/AN/AN/AN/A$3.24 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AFAC
Arena Fortify Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$49.27M$0.702.51N/AN/A12.94%12.39%10.68%5/9/2024 (Estimated)
GEEX
Games & Esports Experience Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Hour Loop, Inc. stock logo
HOUR
Hour Loop
-$2.43M-$0.07N/AN/A-1.84%-49.19%-11.69%5/10/2024 (Estimated)
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
$4.41MN/A0.00N/AN/A-21.83%3.10%N/A
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
-$6.61M-$1.42N/A9.832.21-14.09%-2.82%-1.27%5/20/2024 (Estimated)
Smart for Life, Inc. stock logo
SMFL
Smart for Life
-$29.98M-$1,115.67N/AN/A-188.32%N/A-75.82%5/27/2024 (Estimated)
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
-$82.64M-$2.13N/AN/AN/AN/A-57.26%-49.50%5/8/2024 (Estimated)

Latest MDV, AMLX, VIGL, LGST, TOAC, IOACU, AFAC, GEEX, SMFL, and HOUR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
Hour Loop, Inc. stock logo
HOUR
Hour Loop
N/A-$0.01-$0.01-$0.01N/A$59.49 million
3/26/2024Q4 2023
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
-$0.56-$0.57-$0.01-$0.57N/AN/A
3/4/202412/31/2023
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
$0.38$0.03-$0.35-$0.29$12.53 million$12.29 million    
2/22/202412/31/2023
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$0.20$0.23+$0.03$0.07$106.40 million$108.45 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AFAC
Arena Fortify Acquisition
N/AN/AN/AN/AN/A
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
N/AN/AN/AN/AN/A
GEEX
Games & Esports Experience Acquisition
N/AN/AN/AN/AN/A
Hour Loop, Inc. stock logo
HOUR
Hour Loop
N/AN/AN/AN/AN/A
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
N/AN/AN/AN/AN/A
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
N/AN/AN/AN/AN/A
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
$1.157.70%N/AN/A N/A
Smart for Life, Inc. stock logo
SMFL
Smart for Life
N/AN/AN/AN/AN/A
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
N/AN/AN/AN/AN/A
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
N/AN/AN/AN/AN/A

Latest MDV, AMLX, VIGL, LGST, TOAC, IOACU, AFAC, GEEX, SMFL, and HOUR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/20/2024
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
monthly$0.09587.1%6/28/20246/28/20247/25/2024
3/19/2024
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
monthly$0.09587.1%5/31/20245/31/20246/25/2024
3/18/2024
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
$0.09584/29/20244/30/20245/28/2024
(Data available from 1/1/2013 forward)

Debt

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AFAC
Arena Fortify Acquisition
2,02121.56 million17.94 millionNot Optionable
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
38467.78 million59.78 millionOptionable
GEEX
Games & Esports Experience Acquisition
2,02125.00 million20.05 millionNot Optionable
Hour Loop, Inc. stock logo
HOUR
Hour Loop
17835.10 million1.72 millionNot Optionable
Innovative International Acquisition Corp. stock logo
IOACU
Innovative International Acquisition
2,021N/AN/ANot Optionable
Semper Paratus Acquisition Co. stock logo
LGST
Semper Paratus Acquisition
2,02115.82 million6.86 millionNot Optionable
Modiv Industrial, Inc. stock logo
MDV
Modiv Industrial
129.17 million8.75 millionNot Optionable
Smart for Life, Inc. stock logo
SMFL
Smart for Life
145110,00078,000Not Optionable
Talon 1 Acquisition Corp. stock logo
TOAC
Talon 1 Acquisition
2,02115.43 million12.35 millionNot Optionable
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
6937.58 million25.01 millionNot Optionable

MDV, AMLX, VIGL, LGST, TOAC, IOACU, AFAC, GEEX, SMFL, and HOUR Headlines

SourceHeadline
Vigil Neuroscience (NASDAQ:VIGL) Rating Reiterated by JMP SecuritiesVigil Neuroscience (NASDAQ:VIGL) Rating Reiterated by JMP Securities
americanbankingnews.com - April 20 at 1:54 AM
JMP Securities Reaffirms Market Outperform Rating for Vigil Neuroscience (NASDAQ:VIGL)JMP Securities Reaffirms Market Outperform Rating for Vigil Neuroscience (NASDAQ:VIGL)
marketbeat.com - April 18 at 2:21 PM
Vigil Neuroscience Inc: A Strong Buy on Promising ALSP Drug Trial Outcomes and Biomarker BreakthroughsVigil Neuroscience Inc: A Strong Buy on Promising ALSP Drug Trial Outcomes and Biomarker Breakthroughs
markets.businessinsider.com - April 18 at 9:06 AM
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual MeetingVigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
globenewswire.com - April 17 at 4:05 PM
Vigil Neuroscience, Inc. Forecasted to Post Q2 2024 Earnings of ($0.58) Per Share (NASDAQ:VIGL)Vigil Neuroscience, Inc. Forecasted to Post Q2 2024 Earnings of ($0.58) Per Share (NASDAQ:VIGL)
marketbeat.com - March 29 at 8:16 AM
Buy Rating Affirmed for Vigil Neuroscience on Promising Clinical Trials and Key Data ReadoutsBuy Rating Affirmed for Vigil Neuroscience on Promising Clinical Trials and Key Data Readouts
markets.businessinsider.com - March 29 at 8:12 AM
Brokers Issue Forecasts for Vigil Neuroscience, Inc.s Q1 2024 Earnings (NASDAQ:VIGL)Brokers Issue Forecasts for Vigil Neuroscience, Inc.'s Q1 2024 Earnings (NASDAQ:VIGL)
marketbeat.com - March 28 at 8:18 AM
Analysts Offer Insights on Healthcare Companies: Vigil Neuroscience Inc (VIGL) and Daxor (DXR)Analysts Offer Insights on Healthcare Companies: Vigil Neuroscience Inc (VIGL) and Daxor (DXR)
markets.businessinsider.com - March 27 at 12:58 PM
Vigil Neuroscience (NASDAQ:VIGL) Stock Rating Reaffirmed by HC WainwrightVigil Neuroscience (NASDAQ:VIGL) Stock Rating Reaffirmed by HC Wainwright
marketbeat.com - March 27 at 10:15 AM
Buy Rating Affirmed: Vigil Neuroscience’s Advancing TREM2 Programs and Strong Financial PositionBuy Rating Affirmed: Vigil Neuroscience’s Advancing TREM2 Programs and Strong Financial Position
markets.businessinsider.com - March 27 at 7:41 AM
Vigil Neuroscience, Inc. (NASDAQ:VIGL) Forecasted to Earn FY2028 Earnings of ($0.58) Per ShareVigil Neuroscience, Inc. (NASDAQ:VIGL) Forecasted to Earn FY2028 Earnings of ($0.58) Per Share
marketbeat.com - March 27 at 6:34 AM
Vigil Neuroscience, Inc.: Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateVigil Neuroscience, Inc.: Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
finanznachrichten.de - March 26 at 11:28 PM
Vigil Neuroscience GAAP EPS of -$0.57 in-lineVigil Neuroscience GAAP EPS of -$0.57 in-line
msn.com - March 26 at 11:27 PM
Vigil Neuroscience: Q4 Earnings InsightsVigil Neuroscience: Q4 Earnings Insights
benzinga.com - March 26 at 11:27 PM
VIGL Stock Earnings: Vigil Neuroscience Misses EPS for Q4 2023VIGL Stock Earnings: Vigil Neuroscience Misses EPS for Q4 2023
investorplace.com - March 26 at 3:01 PM
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateVigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
globenewswire.com - March 26 at 7:05 AM
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - March 24 at 9:59 AM
Vigil Neuroscience, Inc.: Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical OfficerVigil Neuroscience, Inc.: Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
finanznachrichten.de - March 20 at 5:39 PM
Vigil Neuroscience appoints Kaufmann as Chief Medical OfficerVigil Neuroscience appoints Kaufmann as Chief Medical Officer
seekingalpha.com - March 20 at 5:39 PM
Vigil Neuroscience Appoints Petra Kaufmann As CMOVigil Neuroscience Appoints Petra Kaufmann As CMO
markets.businessinsider.com - March 20 at 5:39 PM
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical OfficerVigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
globenewswire.com - March 20 at 7:05 AM
VIGL Vigil Neuroscience, Inc.VIGL Vigil Neuroscience, Inc.
seekingalpha.com - March 16 at 12:03 AM
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual MeetingVigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
globenewswire.com - March 13 at 7:05 AM
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS DaysVigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
globenewswire.com - March 12 at 7:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Arena Fortify Acquisition

NASDAQ:AFAC
Arena Fortify Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on acquisition candidates within the natural resources industry. The company was incorporated in 2021 and is based in New York, New York.
Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

NASDAQ:AMLX
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Games & Esports Experience Acquisition

NASDAQ:GEEX
Games & Esports Experience Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the interactive media, ecommerce, media, content and other intellectual property, sports and entertainment, and social media industries. The company was incorporated in 2021 and is based in Los Angeles, California.
Hour Loop logo

Hour Loop

NASDAQ:HOUR
Hour Loop, Inc., an online retailer, engages in e-commerce retailing in the United States. The company sells home/garden décor, toys, kitchenware, apparel, and electronics products. It sells its products through hourloop.com and third-party marketplaces. Hour Loop, Inc. was founded in 2013 and is headquartered in Redmond, Washington.
Innovative International Acquisition logo

Innovative International Acquisition

NASDAQ:IOACU
Innovative International Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business transaction with one or more businesses in consumer technology, healthcare, information technology services, and enterprise software as a service. The company was incorporated in 2021 and is based in Dana Point, California. Innovative International Acquisition Corp. operates as a subsidiary of Innovative International Sponsor I LLC.
Semper Paratus Acquisition logo

Semper Paratus Acquisition

NASDAQ:LGST
Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire companies operating in the transportation, supply chain, and logistics industries. Semper Paratus Acquisition Corporation was incorporated in 2021 and is based in New York, New York. Semper Paratus Acquisition Corporation operates as a subsidiary of Ssvk Associates, Llc.
Modiv Industrial logo

Modiv Industrial

NYSE:MDV
Modiv Industrial, Inc. is an internally managed REIT that is focused on single-tenant net-lease industrial manufacturing real estate. The Company actively acquires critical industrial manufacturing properties with long-term leases to tenants that fuel the national economy and strengthen the nation's supply chains.
Smart for Life logo

Smart for Life

NASDAQ:SMFL
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements under the Smart for Life brand; dietary supplements; and nutritional products, including whey protein isolate powder, tablet supplements for joint health, nitric oxide, post workout blends, Omega-3 supplements, and pre-workout supplements under the Sports Illustrated Nutrition brand for athletes and active lifestyle consumers. The company also provides various nutritional products, including antioxidant rich supplements, plant-based proteins, alkalizing nutrients, and weight management products. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Boca Raton, Florida.
Talon 1 Acquisition logo

Talon 1 Acquisition

NASDAQ:TOAC
Talon 1 Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business combination opportunities in the aerospace, aviation, and aviation services industries. The company was incorporated in 2021 and is based in Coral Gables, Florida.
Vigil Neuroscience logo

Vigil Neuroscience

NASDAQ:VIGL
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.